Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-23T10:10:35.288Z Has data issue: false hasContentIssue false

5 - Deciding on Appropriate Treatment Modalities: Medication, Psychotherapy, Hospitalization, and Other Levels of Care

Published online by Cambridge University Press:  25 March 2024

Joseph F. Goldberg
Affiliation:
Icahn School of Medicine at Mount Sinai, New York
Stephen M. Stahl
Affiliation:
University of California San Diego
Get access

Summary

Deciding when psychiatric medications or other types of treatments are indicated – and defining precise targets and goals of treatment – is perhaps the most fundamental of all undertakings in clinical psychiatry. As with all medical treatments, clinicians and patients should both have a clear and explicit understanding of what they expect medications, psychotherapy, or other interventions, to do. Medicines do not fix bad relationships or resolve existential dilemmas, but they can equip people with more intact capabilities to solve problems through better concentration and executive functioning, or improve someone’s capacity to negotiate stresses with less bias and influence from distorted beliefs or intense emotions. Pharmacotherapy is somewhat analogous to eyeglasses when it comes to driving a car; glasses do not confer driving skills but they can help minimize visual obstructions and improve how the brain processes information in ways that might otherwise prevent someone from making the fullest use of their knowledge about the rules of the road. Psychotherapy constitutes driving lessons.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders, 5th edition, text revision. Washington, DC: American Psychiatric Association, 2022Google Scholar
Bibring, E.Psychoanalysis and the dynamic therapies. J Amer Psychoanalytic Assoc 1954; 2: 745770CrossRefGoogle Scholar
Biel, MG, Peselow, E, Mulcare, L, et al.Continuation versus discontinuation of lithium in recurrent bipolar illness: A naturalistic study. Bipolar Disord 2007; 9: 435442CrossRefGoogle ScholarPubMed
Black, D.Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders. CNS Spectr 2006; 10: 2933CrossRefGoogle Scholar
Choy, Y, Fyer, AJ, Lipsitz, JD.Treatment of specific phobias in adults. Clin Psychol Rev 2007; 27: 266286CrossRefGoogle ScholarPubMed
Cleare, A, Pariante, CM, Young, AH, et al.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol 2015; 29: 459525CrossRefGoogle ScholarPubMed
Corbisiero, S, Bitto, H, Newark, P, et al.A comparison of cognitive–behavioral therapy and pharmacotherapy vs. pharmacotherapy alone in adults with attention-deficit/hyperactivity disorder (ADHD) – a randomized controlled trial. Front Psychiatry 2018; 9: 571CrossRefGoogle ScholarPubMed
Crow, SJ.Pharmacotherapy of eating disorders. Psych Clin N Amer 2019; 42: 253262CrossRefGoogle ScholarPubMed
Cuijpers, P, Sijbrandij, M, Koole, SL, et al.The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: A meta-analysis of direct comparisons. World Psychiatry 2013; 12: 137148CrossRefGoogle ScholarPubMed
Cuijpers, P, Sijbrandij, M, Koole, SL, et al.Adding psychotherapy to antidepressant medication in depression and anxiety disorders: A meta-analysis. World Psychiatry 2014; 13: 5667CrossRefGoogle ScholarPubMed
Cuijpers, P, Oud, M, Karyotaki, E, et al.Psychological treatment of depression compared with pharmacotherapy and combined treatment in primary care: A network meta-analysis. Ann Fam Med 2021; 19: 262270CrossRefGoogle ScholarPubMed
De Leo, D, Cerin, E, Spathonis, K, et al.Lifetime risk of suicide ideation and attempts in an Australian community: Prevalence, suicidal process, and help-seeking behavior. J Affect Disord 2005; 86: 215224CrossRefGoogle Scholar
Faedda, GL, Tondo, L, Baldessarini, RJ, et al.Outcome after rapid vs. gradual discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1993; 50: 448455CrossRefGoogle Scholar
Forbes, D, Creamer, M, Bisson, JI, et al.A guide to guidelines for the treatment of PTSD and related conditions. J Traumatic Stress 2010; 23: 537552CrossRefGoogle ScholarPubMed
Francis, A, Clarkin, JF.No treatment as the prescription of choice. Arch Gen Psychiatry 1981; 38: 542545CrossRefGoogle Scholar
Garakani, A, Buono, FD, Larkin, K, et al.Development and validation of a new scale to measure chronic suicidal ideation: The Chronic Suicidal Ideation Inventory-5 (CSI-5). J Affect Disord 2022; 140: 160164Google Scholar
Gelenberg, AJ, Kane, JM, Keller, MB, et al.Comparison of standard and low levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989; 321: 14891493CrossRefGoogle ScholarPubMed
Gelenberg, AJ, Freeman, MP, Markowitz, JC, et al.Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 3rd edition. Washington, DC: American Psychiatric Association, 2010Google Scholar
González-Rodriguez, A, Guàrdia, A, Palao, JD, et al.Moderators and mediators of antipsychotic response in delusional disorder: Further steps are needed. World J Psychiatry 2020; 10: 3445CrossRefGoogle ScholarPubMed
Gupta, S, Cahill, DJ.A prescription for “deprescribing” in psychiatry. Psychiatr Serv 2016; 67: 904907CrossRefGoogle ScholarPubMed
Harrow, M, Jobe, TH.Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery? Schizophr Bull 2013; 39: 962965CrossRefGoogle ScholarPubMed
Huang, X, Fox, KR, Ribeiro, JD, et al.Psychosis as a risk factor for suicidal thoughts and behaviors: A meta-analysis of longitudinal studies. Psychol Med 2018; 48: 765776CrossRefGoogle ScholarPubMed
Huhn, M, Nikolakopoulou, A, Schneider-Thoma, J, et al.Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: A systematic review and network meta-analysis. Lancet 2019; 394: 939951CrossRefGoogle ScholarPubMed
Ingehoven, T, Lafay, P, Rinne, T, et al.Effectiveness of pharmacotherapy for severe personality disorders: Meta-analyses of randomized controlled trials. J Clin Psychiatry 2010; 71: 1425CrossRefGoogle Scholar
Jakobsen, JC, Hansen, JL, Simonsen, S, et al.Effects of cognitive therapy versus interpersonal psychotherapy in patients with major depressive disorder: A systematic review of randomized clinical trials with meta-analyses and trial sequential analyses. Psychol Med 2012; 42: 13431357CrossRefGoogle ScholarPubMed
Laska, KM, Gurman, AS, Wampold, BE.Expanding the lens of evidence-based practice in psychotherapy: a common factors perspective. Psychotherapy (Chic) 2014; 51: 467481CrossRefGoogle ScholarPubMed
Laws, KR, Darlington, N, Kondel, TK, et al.Cognitive behavioural therapy for schizophrenia – outcomes for functioning, distress and quality of life: A meta-analysis. BMC Psychol 2018; 6: 32CrossRefGoogle ScholarPubMed
Lehman, AF, Lieberman, JA, Dixon, LB, et al.Practice Guideline for the Treatment of Patients with Schizophrenia, 2nd edition. Washington, DC: American Psychiatric Association, 2004Google ScholarPubMed
Leucht, S.Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application. J Clin Psychiatry 2014; 75 (suppl 1): 814CrossRefGoogle ScholarPubMed
Liu, X, Momen, NC, Molenaar, N, et al.Discontinuation of antidepressants: Is there a minimum time on treatment that will reduce relapse risk? J Affect Disord 2021; 290: 254260CrossRefGoogle Scholar
Mataix-Cols, D, de la Cruz, LF, Nordsletten, AE, et al.Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive–compulsive disorder. World Psychiatry 2016; 15: 8081CrossRefGoogle ScholarPubMed
Morrison, AP, Law, H, Carter, L, et al.Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: A randomised controlled pilot and feasibility study. Lancet Psychiatry 2018; 5: 411423CrossRefGoogle ScholarPubMed
Obegi, JH.How common is recent denial of suicidal ideation among suicidal ideators, attempters, and suicide decedents? A literature review. Gen Hosp Psychiatry 2021; 72: 9295CrossRefGoogle ScholarPubMed
Oldham, JM, Gabbard, GO, Goin, MK, et al.Practice Guideline for the Treatment of Borderline Personality Disorder. Washington, DC: American Psychiatric Association, 2001.Google Scholar
Roshanaei-Moghaddam, B, Pauly, MC, Atkins, DC, et al.Relative effects of CBT and pharmacotherapy in depression versus anxiety: Is medication somewhat better for depression, and CBT somewhat better for anxiety? Depress Anxiety 2011; 28: 560567CrossRefGoogle ScholarPubMed
Rothschild, AJ, Wilner, J, Flint, AJ, et al.Missed diagnosis of psychotic depression at 4 academic medical centers. J Clin Psychiatry 2008; 69: 12931296CrossRefGoogle ScholarPubMed
Sachs, GS, Printz, DJ, Kahn, DA, et al.The Expert Consensus Guideline Series for the Treatment of Bipolar Disorder. Memphis, TN: Physicians Postgraduate Press, 2000Google ScholarPubMed
Solomon, DA, Keller, MB, Leon, AC, et al.Multiple recurrences of major depressive disorder. Am J Psychiatry 2000; 157: 229233Google ScholarPubMed
Stein, MB, Goin, MK, Pollack, MH, et al.Practice Guideline for the Treatment of Patients with Panic Disorder, 2nd edition. Washington, DC: American Psychiatric Association, 2010Google Scholar
Varker, T, Kartal, D, Watson, L, et al.Defining response and nonresponse to posttraumatic stress disorder treatments: A systematic review. Clin Psychol: Science and Practice 2020; 27: e12355Google Scholar
Weisaeth, N.Vulnerability and protective factors for posttraumatic stress disorder. Psychiatry Clin Neurosci 1998; 52: S39S44CrossRefGoogle Scholar
Yatham, LN, Beaulieu, S, Schaffer, A, et al.Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode. Mol Psychiatry 2016; 21: 10501056CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×